Biotia Launches Clinical Antimicrobial Resistance Reporting for UTIs

May 20, 2026
Biotia has introduced BIOTIA-DX Resistance, an antimicrobial resistance profiling tool now integrated into its CLEP-approved BIOTIA-ID Urine Test for clinical use across the U.S. The platform provides rapid resistance prediction to guide treatment for complicated urinary tract infections.

Biotia announced in a press release the clinical availability of its BIOTIA-DX Resistance technology, which is now part of the New York State CLEP-approved BIOTIA-ID Urine Test. The system provides rapid antimicrobial resistance profiling for patients with recurrent or complicated urinary tract infections.

The BIOTIA-ID Urine Test enables pathogen detection and resistance prediction directly from urine samples. It supports clinicians by providing actionable resistance data at diagnosis, allowing for more precise antibiotic selection and reduced use of broad-spectrum treatments.

Biotia's BIOTIA-DX Resistance tool achieved top performance in the 2026 CAMDA Antimicrobial Resistance Challenge, marking its second consecutive year as the highest scoring system. The competition benchmarks computational models for predicting resistance profiles using metagenomic data.

The technology is available for clinical use across all 50 U.S. states and is part of Biotia's broader diagnostic platform for infectious disease identification, combining curated genomic references with machine learning models to detect resistance across multiple organisms and drug classes.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.